Oral devices for sleep apnea make up less than 5 per cent of the market in the U.S., which was dominated by ResMed’s mask-based devices. With a European juggernaut underway, the U.S. market is the ultimate prize for SomnoMed.
Oral devices for sleep apnea make up less than 5 per cent of the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
0.020(2.74%) |
Mkt cap ! $163.6M | |||
| Open | High | Low | Value | Volume |
| 75.0¢ | 75.0¢ | 75.0¢ | $18.16K | 24.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 73.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.0¢ | 112368 | 2 |
View Market Depth
| Last trade - 16.10pm 09/09/2025 (20 minute delay) ? |
| SOM (ASX) Chart |